|
|
|
| |
|
August 2010: Where do you perceive a conflict of interest for receiving commercial funds to support the following activities? (check all that apply) |
| Unrestricted Funds to support Department of Medicine/Pharmacy (40, 40.8%) Educational Funds to support Department of Medicine/Pharmacy (38, 38.8%) Post-graduate Continuing Education by Department of Medicine/Pharmacy (26, 26.5%) Post-graduate Continuing Education by a Third Party CE Vendor (37, 37.8%) Post-graduate Continuing Education by an Organization (e.g. CPNP) (19, 19.4%) Department of Medicine/Pharmacy Grand Rounds (37, 37.8%) Investigator Initiated Studies (23, 23.5%) IRB-approved Company Sponsored Research (27, 27.6%) None of the Above (24, 24.5%) |
July 2010: Do you believe it is ethical for otherwise healthy pharmacy students to use prescribed cognitive performance enhancing medications (e.g., methylphenidate, amphetamines) to assist them with their scholastic endeavors? |
| |
June 2010: Medical marijuana is becoming legal in an increasing number of states and is a frequent topic in popular news media. To what extent are you seeing medical marijuana prescribed in your practice setting? |
| |
May 2010: How has the ongoing shortage of prazosin most affected your practice site? |
| a. We have been able to adjust capsule strengths to meet needs (9, 33.3%) b. We have been using more atypical antipsychotics (2, 7.4%) c. We have been using more antiepileptics (0, 0.0%) d. We have been using more benzodiazepines (0, 0.0%) e. We have been using more antidepressants (0, 0.0%) f. We have been using more beta blockers (0, 0.0%) g. We have been using more alpha agonists (clonidine, guanfacine) (3, 11.1%) h. We have not been impacted/None of the above (13, 48.1%) |
April 2010: Several new antipsychotics have recently been marketed in the US. Which second generation antipsychotics do you have, or expect to have, on your formulary this year? |
| olanzapine pamoate (5, 26.3%) paliperidone palmitate (12, 63.2%) risperidone long-lasting injection (13, 68.4%) |
March 2010: Health Care Reform is again moving to the front burner.
President Obama has crafted a new proposal
that incorporates many of the features of both the House and Senate bills as well as
Republican proposals that have been put forth.
A bipartisan meeting took place last week, but the final shape of a future health care system has yet to take shape. What do you expect will be the outcome of this renewed debate? |
| A. Nothing. Health Care Reform is dead. (11, 37.9%) B. A very watered down version of the President's proposal will be passed into law. (7, 24.1%) C. The Republican proposals in the President's draft will be increased and dominate the final bill that is passed into law. (1, 3.4%) D. Insurance reforms and some subsidies for the uninsured poor will be passed into law. (9, 31.0%) E. A proposal similar to the Democratic's bills will be passed into law. A single payer system will be adopted this year. (1, 3.4%) |
February 2010: Following the publication of the double-blind study in AJP regarding INITIAL treatment of MDD, what have you seen in your practice? |
| A. The same amount of prescribing of combination antidepressants (we frequently do this) (11, 50.0%) B. The same amount of prescribing of combination antidepressants (we rarely do this) (8, 36.4%) C. A perceived increase in the prescribing of combination antidepressants (3, 13.6%) D. A perceived decrease in the prescribing of combination antidepressants (0, 0.0%) |
January 2010: What role do pharmacists at your facility play in long acting injectable antipsychotic (depot) clinics? |
| A. Pharmacists administer injections (4, 13.8%) B. They see patients to screen for adverse effects and/or efficacy (6, 20.7%) C. Pharmacists supply and store medications (7, 24.1%) D. They review profiles for polyphamacy (3, 10.3%) E. Pharmacists have no role in the depot clinic (9, 31.0%) |
